Ipodate sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ipodate sodium and what is the scope of patent protection?
Ipodate sodium
is the generic ingredient in two branded drugs marketed by Bayer Hlthcare and Bracco, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for ipodate sodium.
Summary for ipodate sodium
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 418 |
DailyMed Link: | ipodate sodium at DailyMed |
US Patents and Regulatory Information for ipodate sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | BILIVIST | ipodate sodium | CAPSULE;ORAL | 087768-001 | Aug 11, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | ORAGRAFIN SODIUM | ipodate sodium | CAPSULE;ORAL | 012967-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |